Assessment of Quizartinib Pharmacokinetic in Subjects With Severe Hepatic Impairment

Recruiting

Phase 1

QuizartinibAssessment of Quizartinib Pharmacokinetic in Subjects With Severe Hepatic Impairment

Sponsor:

Daiichi Sankyo

Code:

NCT06740799

Conditions

Hepatic Impairment

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Interventions

Quizartinib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-05. This information was provided to ClinicalTrials.gov by Daiichi Sankyo on 2026-04-01.